Trials / Recruiting
RecruitingNCT06349681
Describe Relations Between qCON and qNOX Indicies During Propofol-Remifentanil General Anesthesia
Describe Relationship Between qCON and qNOX of the CONOX Monitor During General Anesthesia Perfromed With Propofol and Remifentanil Target Controlled Infusion (TCI)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (estimated)
- Sponsor
- University of Padova · Academic / Other
- Sex
- Female
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia. It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bewtween the 2 indicies.
Detailed description
CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia. It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bwtween the 2 indicies, as well as with EMG, Concentration of Propofol (CeP) and Remifentanil (CeR) during Total Intravenous Anesthesia with Target Controlled Infusion (TIVA-TCI).
Conditions
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2024-09-01
- Completion
- 2024-10-01
- First posted
- 2024-04-05
- Last updated
- 2024-04-25
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06349681. Inclusion in this directory is not an endorsement.